Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$3.28 - $4.81 $46,559 - $68,277
14,195 Added 7.81%
196,061 $678,000
Q4 2022

Feb 13, 2023

BUY
$3.65 - $4.82 $146,365 - $193,282
40,100 Added 28.29%
181,866 $814,000
Q3 2022

Nov 10, 2022

BUY
$2.66 - $3.97 $2,332 - $3,481
877 Added 0.62%
141,766 $516,000
Q2 2022

Aug 12, 2022

SELL
$2.42 - $4.05 $25,956 - $43,440
-10,726 Reduced 7.07%
140,889 $374,000
Q1 2022

May 16, 2022

BUY
$3.45 - $5.83 $34,734 - $58,696
10,068 Added 7.11%
151,615 $595,000
Q4 2021

Feb 14, 2022

SELL
$4.89 - $7.59 $55,110 - $85,539
-11,270 Reduced 7.37%
141,547 $781,000
Q3 2021

Nov 12, 2021

BUY
$5.18 - $7.41 $32,608 - $46,645
6,295 Added 4.3%
152,817 $1.1 Million
Q2 2021

Aug 16, 2021

BUY
$3.94 - $6.75 $166,212 - $284,755
42,186 Added 40.43%
146,522 $967,000
Q1 2021

May 14, 2021

SELL
$4.03 - $7.25 $111,038 - $199,759
-27,553 Reduced 20.89%
104,336 $454,000
Q4 2020

Feb 12, 2021

BUY
$2.78 - $4.5 $107,274 - $173,646
38,588 Added 41.36%
131,889 $503,000
Q3 2020

Nov 13, 2020

SELL
$2.12 - $3.53 $10,135 - $16,876
-4,781 Reduced 4.87%
93,301 $327,000
Q2 2020

Aug 12, 2020

BUY
$1.66 - $2.73 $77,261 - $127,062
46,543 Added 90.31%
98,082 $220,000
Q1 2020

May 13, 2020

SELL
$1.35 - $4.05 $14,643 - $43,930
-10,847 Reduced 17.39%
51,539 $129,000
Q4 2019

Feb 12, 2020

BUY
$2.3 - $4.6 $51,802 - $103,605
22,523 Added 56.5%
62,386 $263,000
Q3 2019

Nov 12, 2019

SELL
$2.9 - $9.56 $45,596 - $150,311
-15,723 Reduced 28.29%
39,863 $115,000
Q2 2019

Aug 14, 2019

BUY
$6.7 - $9.13 $127,943 - $174,346
19,096 Added 52.33%
55,586 $489,000
Q1 2019

May 14, 2019

BUY
$5.7 - $8.73 $61,913 - $94,825
10,862 Added 42.38%
36,490 $270,000
Q4 2018

Feb 13, 2019

BUY
$5.04 - $10.28 $57,743 - $117,777
11,457 Added 80.85%
25,628 $155,000
Q3 2018

Nov 13, 2018

SELL
$7.12 - $12.44 $12,680 - $22,155
-1,781 Reduced 11.16%
14,171 $133,000
Q2 2018

Aug 14, 2018

BUY
$6.21 - $8.21 $9,991 - $13,209
1,609 Added 11.22%
15,952 $110,000
Q1 2018

May 15, 2018

BUY
$6.26 - $10.12 $89,787 - $145,151
14,343 New
14,343 $92,000
Q4 2017

Feb 14, 2018

SELL
$5.6 - $9.9 $114,458 - $202,346
-20,439 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$4.73 - $6.16 $96,676 - $125,904
20,439
20,439 $117,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.